Mochi Health Reviews: What Trustpilot Ratings Reveal About Service

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health holds a 4.5-star rating on Trustpilot from approximately 18,000 reviews (captured September 4, 2026), placing it among the higher-rated telehealth weight-management platforms. Starting-dose pricing is economically competitive: $99/month for compounded semaglutide and $129/month for compounded tirzepatide during the first month, both figures including a $39 first-month membership fee and starting-dose medication cost. However, individual Trustpilot reports describe challenges reaching providers after initial consultation, and the platform's per-dose pricing model means cost rises with titration—a structure that can make year-one budgeting difficult without dose-escalation transparency. PlexusDx charges $189/month for semaglutide injection and $289/month for tirzepatide injection at every dose with no membership fee, holds a 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher, captured September 9, 2026), and includes messaging access to U.S.-licensed providers in every subscription. Our September 2026 evidence review did not capture Mochi Health's shipping policies, support-channel hours, or ongoing membership cost beyond the first month; readers should confirm those details at checkout.

At-a-glance comparison

Sources: Mochi Health website, Trustpilot (both captured September 4, 2026); PlexusDx product pages (September 7, 2026).

What Trustpilot reviews reveal about Mochi Health service

Mochi Health's 4.5-star aggregate on Trustpilot from approximately 18,000 reviews positions the platform in the upper tier of GLP-1 telehealth services by volume and rating. However, individual negative reports describe challenges reaching a provider after the initial consultation—a theme that matters when dose adjustments, side-effect questions, or prescription changes require clinical input. One representative anecdote captured in our September 2026 evidence review described a patient unable to secure timely follow-up when experiencing nausea during titration.

Trustpilot review evidence reflects individual experiences and allegations, not systematically verified outcomes. The 4.5-star average indicates that the majority of reviewers report satisfaction, yet the provider-engagement theme suggests variability in post-enrollment clinical access. Our evidence review did not capture Mochi Health's stated support-channel hours, response-time commitments, or patient-to-provider ratio, so readers evaluating continuity of care should confirm those operational details directly.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). The majority of PlexusDx reviews describe responsive messaging access to U.S.-licensed clinicians and straightforward dose-adjustment workflows, and messaging support is included in every subscription without separate consultation fees.

Pricing structure: per-dose model vs. flat monthly rate

Mochi Health charges separately for medication and membership. Starting-dose compounded semaglutide costs $60/month, and compounded tirzepatide costs $90/month; the first-month membership fee is $39. This structure produces a first-month all-in cost of $99 for semaglutide and $129 for tirzepatide at starting doses (both captured September 4, 2026). Mochi Health uses a per-dose pricing model, meaning medication cost increases as the prescriber titrates dose upward. Our evidence did not document the membership cost beyond the first month or provide a dose-escalation price schedule, so projecting year-one total cost requires assumptions the evidence does not support.

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection at every dose, with no membership fee and no price change during titration. Over 12 months at the month-to-month rate, semaglutide costs $2,268 and tirzepatide costs $3,468 (our calculation). PlexusDx also offers lower per-month rates on 3-month and 6-month prepaid plans.

Normalized 12-month cost: calculation limits

A like-for-like 12-month comparison between Mochi Health and PlexusDx is not possible with the evidence captured. Mochi Health's per-dose model means the medication line item rises with titration—common GLP-1 protocols escalate dose every four weeks until the patient reaches maintenance or tolerability ceiling—but our September 2026 evidence did not document medication pricing above the starting dose or confirm the ongoing membership cost beyond month one. If we assume the membership fee remains $39/month beyond the first month (unconfirmed in evidence) and medication cost stays at the starting-dose rate (unrealistic for most patients who titrate), Mochi Health semaglutide would total $1,188 over 12 months ($60 medication × 12 = $720, plus $39 membership × 12 = $468); tirzepatide would total $1,548 ($90 medication × 12 = $1,080, plus $39 membership × 12 = $468). Both figures are our calculation under assumptions the evidence does not support, and both understate real cost if dose titrates or membership renews at a higher rate.

PlexusDx's flat-rate structure eliminates dose-escalation budgeting complexity: $2,268/year semaglutide, $3,468/year tirzepatide at the month-to-month rate, regardless of dose. Readers requiring predictable year-one costs and transparent titration pricing should confirm Mochi Health's full dose schedule and ongoing membership rate at checkout.

Service-quality decision factors

Strengths: Mochi Health

• High aggregate rating: 4.5 stars from ~18,000 Trustpilot reviews indicates broad satisfaction among enrolled patients (September 2026).
• Competitive starting-dose economics: $99/month first-month semaglutide and $129/month first-month tirzepatide are below the market median for compounded GLP-1 telehealth at starting doses.
• Separate medication and membership billing: may offer flexibility for patients pausing or adjusting therapy, though cancellation terms were not documented in our evidence.

Gaps and uncertainties: Mochi Health

• Provider-access variability: Individual Trustpilot reports describe difficulty reaching clinicians post-enrollment for dose adjustments and side-effect management; the platform's provider-to-patient ratio and response-time commitments were not documented.
• Per-dose pricing opacity: Cost increases with titration, but our evidence did not capture a dose-escalation price schedule, making year-one budgeting difficult without direct confirmation.
• Ongoing membership cost unconfirmed: Evidence documents $39 first-month membership; the recurring rate beyond month one is not stated, creating uncertainty in total-cost projections.
• Shipping and support policies not documented: Our September 2026 review did not capture shipping carrier, delivery timelines, support-channel hours, or response-time commitments.

Strengths: PlexusDx

• Flat-rate dose pricing: $189/month semaglutide and $289/month tirzepatide at every dose eliminates titration budgeting uncertainty.
• No membership fee: One all-inclusive price covers provider visit, prescription, compounded medication, and shipping.
• Included messaging access: U.S.-licensed clinicians available via secure messaging for dose adjustments, side-effect questions, and prescription changes at no additional consultation fee.
• Verified review record: 4.3-star Trustpilot rating with 79% five-star and 83% four-star-or-higher distribution; majority of reviews describe responsive clinical support and straightforward workflows.

Where PlexusDx may not fit

• Higher starting-dose cost: PlexusDx semaglutide ($189/month) and tirzepatide ($289/month) exceed Mochi Health's first-month starting-dose rates, though the comparison inverts if Mochi Health's per-dose pricing rises significantly during titration or membership renews above $39.
• Month-to-month rate positioning: Readers prioritizing the lowest possible first-month cost and comfortable with per-dose escalation may find Mochi Health's entry pricing attractive, provided they confirm the full dose schedule and ongoing membership cost.

Choose Mochi Health if…

• You prioritize the lowest starting-dose entry cost and the 4.5-star Trustpilot rating outweighs individual provider-access reports in your risk assessment.
• You are comfortable with per-dose pricing that increases during titration and willing to confirm the full dose schedule and ongoing membership rate before enrollment.
• You plan to remain at or near the starting dose for an extended period, minimizing the per-dose escalation impact.

Choose PlexusDx if…

• You want year-one cost certainty with the same monthly price at every dose and no membership fee to track.
• You value included messaging access to U.S.-licensed providers for dose adjustments, side-effect questions, and prescription changes without separate consultation fees.
• You prefer a transparent all-in-one subscription (provider visit, prescription, medication, shipping) over separately billed medication and membership components.
• The 4.3-star Trustpilot rating with 83% four-star-or-higher reviews and majority-positive feedback on clinical responsiveness aligns with your service-quality threshold.

Evidence limitations and confirmation steps

Our September 2026 evidence review captured Mochi Health's Trustpilot rating, starting-dose medication pricing, first-month membership fee, and one representative provider-engagement theme from individual reviews. The review did not document:

• Ongoing membership cost beyond the first month
• Medication pricing above the starting dose (the per-dose escalation schedule)
• Shipping carrier, delivery timelines, or shipping-delay frequency
• Support-channel hours, response-time commitments, or patient-to-provider ratios
• Cancellation, refund, or membership-pause policies

Readers evaluating Mochi Health should confirm these operational and cost details directly at checkout or via the platform's support channels. Trustpilot reports describe individual experiences and allegations; they are not systematically verified outcomes and should be weighed alongside aggregate rating and review volume.

Methodology and freshness

We captured Mochi Health pricing, Trustpilot rating, and service evidence on September 4, 2026, and PlexusDx product pages on September 7, 2026. All prices reflect month-to-month rates at starting doses where applicable; Mochi Health uses a per-dose model where cost rises with titration, and the first-month membership fee may differ from ongoing membership cost. The 12-month cost assumptions for Mochi Health (holding medication and membership at starting/first-month rates) are our calculation and understate realistic year-one costs for patients who titrate. PlexusDx 12-month figures are our calculation (monthly rate × 12). Trustpilot ratings and review volumes are as displayed on September 4, 2026; individual review themes are paraphrased from captured examples and labeled as anecdotes or allegations. We did not manually code the full review corpus for shipping or support themes due to evidence-capture scope. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Frequently Asked Questions

What is Mochi Health's Trustpilot rating as of September 2026?

Mochi Health holds a 4.5-star rating on Trustpilot from approximately 18,000 reviews captured September 4, 2026. This places the platform among the higher-rated GLP-1 telehealth services by aggregate score and review volume, though individual reports describe variability in provider access post-enrollment.

How does Mochi Health's pricing compare to PlexusDx at starting doses?

Mochi Health charges $99/month for semaglutide and $129/month for tirzepatide during the first month (medication plus first-month membership), both below PlexusDx's $189 semaglutide and $289 tirzepatide flat monthly rates. However, Mochi Health uses per-dose pricing that increases with titration, and our evidence did not document the escalation schedule or ongoing membership cost.

Does Mochi Health include provider messaging access?

Our September 2026 evidence review did not document Mochi Health's support-channel structure, hours, or response-time commitments. Individual Trustpilot reports describe challenges reaching providers after initial consultation, suggesting variability in post-enrollment clinical access. Readers should confirm provider-access terms directly.

What shipping and support policies does Mochi Health offer?

Our evidence review did not capture Mochi Health's shipping carrier, delivery timelines, support-channel hours, or response-time commitments as of September 2026. Readers evaluating the platform should confirm shipping policies, customer-service availability, and operational details at checkout or via the platform's support team.

Is Mochi Health's per-dose pricing model better than a flat monthly rate?

Per-dose pricing offers a lower entry cost at starting doses but increases during titration, making year-one budgeting difficult without a published escalation schedule. Flat-rate models like PlexusDx eliminate dose-related cost surprises and simplify total-cost projections. The better model depends on your dose trajectory, budget predictability preference, and willingness to confirm escalation pricing.

Sources

• PlexusDx product pages (semaglutide injection, tirzepatide injection), accessed September 7, 2026
• Mochi Health website (pricing, membership, medication offerings), accessed September 4, 2026
• Trustpilot (Mochi Health and PlexusDx ratings, review volumes, individual review themes), accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.